Czech/SlovakiaCzech RepublicSlovakia

New Brno-based life sciences centre opens up for business

05.12.2011

Brno – Czech Prime Minister Petr Necas has officially inaugurated the first of six European Technology Institutes slated to be launched in the Czech Republic with help from European FEDER funds. Although construction of the €200m Central European Institute of Technology (CEITEC) will not be complete until 2014, the life sciences research centre – made up of ten facilities – has already begun operations. Following a workshop with EMBL researchers, CEITEC deputy director Ondrej Hradil announced in mid-November that the center has already been approached with several proposals for cooperation in the fields of bioinformatics, innovative sequencing techniques and development of new methods of advanced optical microscopy. Up to now, the Czech Republic has not been an EMBL member country, but CEITEC would support negotiations on its membership. Earlier in November, CEITEC ordered four ultra-high field AVANCETM NMR systems from Bruker, which will make it the premier biological NMR research facility in Central and Eastern Europe. “High-field NMR spectroscopy will be combined with other progressive high-resolution methods of structural analysis here such as single-crystal X-ray diffraction, high-end cryo-electron microscopy and tomography, and an atomic force microscopy for understanding of the vital cellular processes,” said Vladimir Sklenar, the Structural Biology Programme Coordinator at CEITEC.

Boost for biotech clusters

Bringing Brno-based research institutes into the CEITEC cluster is part of a more general governmental initiative aimed at creating big research hubs that attract foreign investment and companies. According to the Prague Post, CEITEC is already in discussions with 100 companies that want to pursue research at the site.
The other sites scheduled for opening are also designed to boost bio­technology in the Czech Republic. Along with CEITEC, Prague is aiming to launch an International Clinical Research Centre (ICRC), a Biotechnology and Biomedicine Research Centre (BIOCEV), a Sustainable Energy Centre (SUSEN), an Information Technology for Innovations (IT4I) hub, and an Extreme Light Infrastructure (ELI) cluster. 70% of the costs will be covered by state or EU funding, the rest is to be funded by private investors.

Czech/SlovakiaCzech RepublicSlovakia

11.07.2007

Prague/Foster City – An oligonucleotide analogon, originally developed at the Institute of Organic Chemistry and Biochemistry (IOCB) at the Czech Academy of Sciences in Prague, has entered clinical testing as treatment for...

Czech/SlovakiaCzech RepublicSlovakia

17.05.2007

Prague/Leuven – The Czech Republic is lagging behind in applying the ten year-old European convention on Human rights and biomedicine, according to a new report from EuroGentest, an EU-funded Network of Excellence, which assesses...

Czech/SlovakiaCzech RepublicSlovakia

21.11.2006

BIOTEC 2006, the first international biotechnology conference and exhibition in Eastern Europe, held at the end of October, staged the official inauguration ceremony of the International Clinical Research Center (ICRC). The...

Czech/SlovakiaCzech RepublicSlovakia

16.09.2006

In order to keep track of developments and to promote network-creation, for both domestic-domestic and domestic-foreign cooperations the South Moravian Innovation Centre, Brno, has conducted the Czech Republic’s first...

Czech/SlovakiaCzech RepublicSlovakia

21.07.2006

Bratislava – In late-April, the Slovak government authorized field trials with genetically modified MON 810 maize at three undisclosed locations. The total area of the field trials is approximately 30 hectares. Although Slovakia...

Czech/SlovakiaCzech RepublicSlovakia

21.07.2006

Pruhonice – Biomass production is a promising alternative for the Czech Republic’s agricultural sector. Biomass could cover the annual domestic bio-energy demand of 250 PJ (predicted for 2030), and could be exported as bio-fuels...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2006

Prague - The French pharma giant Sanofi-Aventis S.A. strengthened its generics business in Central and Eastern Europe (CEE) with a participation in the Czech generics producer Zentiva a.s. According to Sanofi-Aventis, the company...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2006

Brno - The International Clinical Research Center (ICRC) in Brno, will collaborate with the renowned Mayo Clinic in Rochester, MN, to establish a clinical and research education center that meets the challenges of 21st-century...

Czech/SlovakiaCzech RepublicSlovakia

17.03.2006

Humpolec - A product derived from genetically modified potatos with altered starch composition poses no threat to human health, according to a European Food Safety Authority (EFSA) panel ruling.BASF Plant Science's GM potato,...

Czech/SlovakiaCzech RepublicSlovakia

17.03.2006

Brno - Spinning out a company in the Czech Republic is far from common. That has not stopped Jiri Damborsky, who led a protein engineering group at Masaryk University, Brno, from founding his own company, Enantis. His firm will...

Displaying results 31 to 40 out of 70

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-czech-slovakia/browse/3/article/new-brno-based-life-sciences-centre-opens-up-for-business.html

Events

All Events

Stock list

All quotes

TOP

  • WILEX2.48 EUR3.77%
  • 4SC1.12 EUR2.75%
  • VITA 344.00 EUR2.04%

FLOP

  • ADDEX2.99 CHF-7.14%
  • BIOFRONTERA2.18 EUR-5.22%
  • SARTORIUS94.26 EUR-3.32%

TOP

  • SANTHERA92.00 CHF43.5%
  • CO.DON3.02 EUR26.9%
  • PAION2.98 EUR19.7%

FLOP

  • EVOTEC3.00 EUR-20.0%
  • ADDEX2.99 CHF-18.5%
  • 4SC1.12 EUR-15.8%

TOP

  • SANTHERA92.00 CHF2211.6%
  • CO.DON3.02 EUR247.1%
  • PAION2.98 EUR189.3%

FLOP

  • CYTOS0.24 CHF-94.0%
  • MERCK KGAA67.23 EUR-41.4%
  • THERAMETRICS0.09 CHF-40.0%

No liability assumed, Date: 16.09.2014


Current issue

All issues

Product of the week

Products